Treatment of Adolescent Suicide Attempters (TASA)

This study has been completed.
Sponsor:
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00080158
First received: March 24, 2004
Last updated: July 17, 2008
Last verified: July 2008

March 24, 2004
July 17, 2008
March 2004
 
 
 
Complete list of historical versions of study NCT00080158 on ClinicalTrials.gov Archive Site
 
 
 
 
 
Treatment of Adolescent Suicide Attempters (TASA)
 

The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.

Suicide is the third leading cause of death in adolescents and is a major public health problem. Depression is the most common diagnosis for adolescent suicide attempts. Little is known about what treatment is best for these adolescents since they are usually excluded from participation in research studies.

Participants in this study will be randomly assigned to receive carefully monitored antidepressant medication with routine support and management, cognitive behavioral therapy (CBT), or a combination of antidepressant medication plus CBT.

Interventional
Phase 2
Phase 3
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Depression
  • Suicide, Attempted
  • Drug: fluoxetine
  • Drug: sertraline
  • Drug: citalopram
  • Drug: escitalopram
  • Drug: bupropion
  • Drug: mirtazapine
  • Drug: venlafaxine
  • Drug: lithium
  • Behavioral: Cognitive Behavioral Therapy
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
June 2007
 

Inclusion Criteria:

  • At least one suicide attempt or interrupted attempt within the past 45 days
  • Continuously reside with a primary caretaker (parent, legal guardian, foster parent) for at least 6 months that can provide legal consent
Both
12 Years to 18 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00080158
U10 MH66762, U10 MH066775, U10 MH066778, U10 MH066769, U10 MH066750, DDTR B4-ARD
 
 
National Institute of Mental Health (NIMH)
 
Study Chair: Laurence Greenhill, MD
National Institute of Mental Health (NIMH)
July 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP